FSMEX Performance — Select Medical Technology and Devices Portfolio
Data updated: 2026-07-24
FSMEX returned −15.75% year to date and −10.19% over one year to May 2026. Annualised returns are −1.17% over 3 years and −3.16% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $97, against $131 for the category, and to $90 over one year, against $129. Volatility over the past three years was 17.15% a year. In the 12 months to May 2026 the fund lost a net $530.3M, and assets reached $2.98B.
FSMEX Growth of $100
What $100 invested in Select Medical Technology and Devices Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | FSMEX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $90 | $129 |
| 3 years (Jun 2023 – May 2026) | $97 | $131 |
| 5 years (Jun 2021 – May 2026) | $85 | $116 |
| Since data start (Sep 2019 – May 2026) | $130 | $173 |
FSMEX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −15.75% |
| 1 year | −10.19% |
| 3 years (annualised) | −1.17% |
| 5 years (annualised) | −3.16% |
FSMEX Annual Returns
Calendar-year total returns of Select Medical Technology and Devices Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −15.75% |
| 2025 | +4.81% |
| 2024 | +9.90% |
| 2023 | +0.62% |
| 2022 | −24.83% |
| 2021 | +24.44% |
| 2020 | +30.02% |
| 2019 (Sep–Dec) | +9.38% |
FSMEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.8% | −4.5% | −9.3% | −2.2% | +2.4% | — | — | — | — | — | — | — |
| 2025 | +7.5% | −3.5% | −5.8% | −0.8% | +1.4% | +1.7% | −2.9% | +2.6% | −2.6% | +5.0% | +5.9% | −2.8% |
| 2024 | +2.4% | +3.9% | +2.5% | −4.8% | −0.5% | +0.1% | +0.4% | +6.4% | +1.7% | −3.3% | +5.0% | −3.6% |
| 2023 | +3.3% | −3.1% | +4.9% | +1.2% | −4.8% | +5.0% | −0.5% | −4.3% | −8.1% | −9.9% | +10.2% | +9.0% |
| 2022 | −14.2% | −0.8% | +2.4% | −13.3% | −2.2% | −5.2% | +10.3% | −6.3% | −5.3% | +3.5% | +7.2% | −1.3% |
| 2021 | +4.7% | −1.6% | 0.0% | +7.9% | −3.5% | +6.3% | +6.1% | +4.2% | −4.2% | +5.1% | −5.5% | +3.7% |
| 2020 | +0.3% | −7.4% | −7.4% | +14.4% | +4.7% | +2.1% | +11.0% | +0.4% | +0.7% | +1.0% | +5.2% | +3.7% |
| 2019 | — | — | — | — | — | — | — | — | −1.6% | +2.1% | +6.2% | +2.4% |
FSMEX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 17.15%
- 3-year Sharpe ratio: -0.33 (vs 4.5% risk-free rate)
- Best month: +10.24% (Nov 2023)
- Worst month: −9.92% (Oct 2023)
FSMEX Fund Flows
Monthly money in and out of Select Medical Technology and Devices Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$530.3M
- 12-month gross sales (incl. reinvestments): $701.0M
- Sales ÷ redemptions: 0.57×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $21.3M | $133.6M | −$112.3M |
| Apr 2026 | $393.1M | $132.0M | $261.1M |
| Mar 2026 | $10.2M | $77.2M | −$66.9M |
| Feb 2026 | $10.8M | $94.5M | −$83.7M |
| Jan 2026 | $12.0M | $103.4M | −$91.4M |
| Dec 2025 | $192.6M | $98.9M | $93.7M |
| Nov 2025 | $9.6M | $70.3M | −$60.7M |
| Oct 2025 | $15.8M | $105.1M | −$89.3M |
| Sep 2025 | $7.6M | $105.5M | −$97.9M |
| Aug 2025 | $10.6M | $102.6M | −$92.0M |
| Jul 2025 | $10.3M | $126.4M | −$116.1M |
| Jun 2025 | $7.0M | $81.9M | −$74.9M |
FSMEX Assets Under Management
Net assets of Select Medical Technology and Devices Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $2.98B |
| 2026-02-28 | $3.65B |
| 2025-11-30 | $4.34B |
| 2025-08-31 | $4.26B |
| 2025-05-31 | $4.48B |
| 2025-02-28 | $5.00B |
| 2024-11-30 | $5.29B |
| 2024-08-31 | $5.36B |
| 2024-05-31 | $5.39B |
| 2024-02-29 | $5.87B |
| 2023-11-30 | $5.45B |
| 2023-08-31 | $6.48B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.